ObjectivesTo evaluate the potential improvement of prediction performance of a proposed double branch multimodality-contribution-aware TripNet (MCAT) in microvascular invasion (MVI) of hepatocellular carcinoma (HCC) based on a small sample. MethodsIn this retrospective study. 121 HCCs from 103 consecutive patients were included. with 44 MVI positive and 77 MVI negative. https://parisnaturalfoodes.shop/product-category/immunol/